Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05799521
PHASE2
A Nasal Treatment for COVID-19
Sponsor: Indiana University
View on ClinicalTrials.gov
Summary
The goal of this study is to test an investigational new inhaled medication called Optate.
Official title: A Novel Nasal Treatment for COVID-19
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-06-27
Completion Date
2026-03-30
Last Updated
2025-12-22
Healthy Volunteers
Yes
Interventions
DRUG
Optate
Alkaline Buffer
DRUG
Placebo
Normal Saline
Locations (1)
Riley Hospital for Children
Indianapolis, Indiana, United States